![](/img/cover-not-exists.png)
O-095 A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small cell lung cancer — A randomised multicentre trial of the British thoracic oncology group (BTOG1)
Lorigan, P.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80229-6
Date:
July, 2005
File:
PDF, 138 KB
english, 2005